Organovo Holdings (FRA:4OR1) Institutional Ownership : 5.41% (As of Jun. 03, 2024)

View and export this data going back to 2013. Start your Free Trial

What is Organovo Holdings Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Organovo Holdings's institutional ownership is 5.41%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Organovo Holdings's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Organovo Holdings's Float Percentage Of Total Shares Outstanding is 87.66%.

Organovo Holdings Institutional Ownership Historical Data

The historical data trend for Organovo Holdings's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Organovo Holdings Institutional Ownership Chart

Organovo Holdings Historical Data

The historical data trend for Organovo Holdings can be seen below:

	2023-07-31	2023-08-31	2023-09-30	2023-10-31	2023-11-30	2023-12-31	2024-01-31	2024-02-29	2024-03-31	2024-04-30
Institutional Ownership	8.59	8.56	8.61	6.65	6.55	7.18	7.21	7.07	6.14	5.41

Organovo Holdings Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Organovo Holdings (FRA:4OR1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Organovo Holdings Inc (FRA:4OR1) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

ONVO:USA 4OR1:Germany

Address

11555 Sorrento Valley road, Suite 100, San Diego, CA, USA, 92121

Website

https://www.organovo.com

Organovo Holdings Inc is a biotechnology company, which designs and creates functional and three-dimensional human tissues for medical research and therapeutic applications. It also develops and commercializes a platform technology for the generation of three-dimensional human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. The company collaborates with pharmaceutical and academic partners to develop human biological disease models in three dimensions. Organovo's key instrument platform is the NovoGen Bioprinter. The firm's 3-D bioprinting technologies create tissues using living cells and biocompatible hydrogels.

Organovo Holdings (FRA:4OR1) Headlines

No Headlines